Correction To: Regional Differences in Baseline Disease Activity and Remission Rates Following Golimumab Treatment for RA: Results From the GO-MORE Trial

Clinical Rheumatology - United Kingdom
doi 10.1007/s10067-018-4131-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2020English

Silent Progression in Patients With Rheumatoid Arthritis: Is DAS28 Remission an Insufficient Goal in RA? Results From the German Remission-Plus Cohort

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2017English

Reply To: Anti-Carbamylated Protein Antibodies (Anti-CarP) and Higher Baseline Disease Activity in RA, a Replication Study in Three Cohorts

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Baseline Differences in the HF-ACTION Trial by Sex

American Heart Journal
Cardiovascular MedicineCardiology
2009English

Letter: Effectiveness of Golimumab to Induce Remission in Outpatient Ulcerative Colitis in Italy

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Golimumab for the Treatment of Ulcerative Colitis

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

Anti-Carbamylated Protein Antibodies (Anti-CarP) and Higher Baseline Disease Activity in RA, a Replication Study in Three Cohorts

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

P146 Golimumab in Rheumatoid and Psoriatic Arthritis. The Relationship Between Minimum Serum Concentration, Anti-Golimumab Antibodies and Activity of Disease

2019English

Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of the GO-RAISE Study

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy